The ASCEND program aims to coordinate and accelerate cell and gene therapy clinical trials—an area rich with promise, but complex in execution. Learn more about this new chapter in the CU Anschutz’s commitment to patients with serious and rare diseases: https://bit.ly/4cr0jPT
The Accelerating Solutions for Cell and Gene Therapy Evaluation and Novel Delivery (ASCEND) was created to coordinate and accelerate cell and gene therapy clinical trials at CU Anschutz. Gates Institu...
